Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiroxostat Tablets vs Allopurinol in Gout with Hyperuricemia (Phase III, China)
CTR20254897Phase 3Active
- Sponsor
- Hebei Kaiwei Hengcheng Pharmaceutical
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of topiroxostat in gout, hyperuricemia, sponsored by Hebei Kaiwei Hengcheng Pharmaceutical. Started Dec 2025; status: active.
02
Drugs
topiroxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on CTR20254897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254897.